Facebook Linkedin Mail Twitter
Facebook Linkedin Mail Twitter
    Latest

    Sponsored

    DEFIANCE randomized controlled trial set to provide best assessment of mechanical...

    Adam Pearce - 0

    Expanding the treatment window for the effective management of DVT

    Adam Pearce - 0

    The Arnsberg ClotTriever study reinforces CLOUT registry outcomes

    - 0

    Why might CLOUT and DEFIANCE open the door to a new...

    Adam Pearce - 0

    ABRE 36-month results show sustained patency and clinical improvements in complex...

    Anthony Strzalek - 0

    Iliac side branch devices a “gamechanger” in AAA treatment

    Anthony Strzalek - 0

    New mechanical thrombectomy systems unlock possibilities for the treatment of venous...

    Anthony Strzalek - 0

    Why ClotTriever is a “gamechanger” for the treatment of deep vein...

    Anthony Strzalek - 0

    Long-term data revealed for VICI Venous Stent System

    Jocelyn Hudson - 0

    Vesper DUO Venous Stent System may remove the need to “mix...

    Adam Pearce - 0

    VeClose five-year data give confidence about long-term durability of VenaSeal treatment

    Anthony Strzalek - 0

    VEITH 2019: Abre venous stent study baseline demographic data presented

    Adam Pearce - 0

    First look at CLOUT registry reveals over 75% of DVT patients...

    Anthony Strzalek - 0

    Learn more about the 24-month results of the Venovo Venous Stent...

    BIBA Publishing - 0

    The new Venovo Venous Stent is changing clinical practice

    Anthony Strzalek - 0
    Load more

    Most read

    Features

    Profiles

    Kathleen Oszvath

    Kathleen Ozsvath

    Kush Desai

    Gloria Salazar

    Venous News


    United Kingdom:

    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: [email protected]

    United States:

    BIBA Medical, North America
    155 North Wacker Drive, Suite 4250, Chicago, IL 60606
    TEL: +1 949 723 9309
    Email: [email protected]

    Terms and Conditions | Privacy Policy

    Facebook Linkedin Mail Twitter